Literature DB >> 21150418

Laparoscopic surgery for primary retroperitoneal tumors: a single institution experience of 14 cases.

Zhipeng Zhang1, Dianrong Xiu.   

Abstract

OBJECTIVE: To evaluate the feasibility and outcomes of laparoscopic surgery for primary retroperitoneal tumors (PRTs).
METHODS: Between January 2007 and July 2009, laparoscopic resection was attempted of PRT in 14 patients. The histological type of the tumor, operating characteristics, and outcomes were analyzed.
RESULTS: In the 14 patients (4 male), the median age was 44 years, with a median tumor diameter of 7.6 cm. Laparoscopic resection was successfully performed in 13 patients with a solely laparoscopic approach (n=11) or combined with a hand-assistant procedure (n=2). One case (epithelioid hemangioma) was converted to laparotomy. The median operating time for laparoscopy was 139 minutes with an estimated average blood loss of 59.2 mL. There were no transfusions or major complications. After a median follow-up of 17 months, all patients remained disease free.
CONCLUSIONS: Laparoscopic surgery for the resection of PRT is feasible and effective when performed by an experienced surgeon.

Entities:  

Mesh:

Year:  2010        PMID: 21150418     DOI: 10.1097/SLE.0b013e3181fd2278

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  3 in total

1.  Laparoscopic Excision of Retroperitoneal Schwannoma.

Authors:  J S Rajkumar; Deepa Ganesh; J R Anirudh; S Akbar; C M Kishore
Journal:  J Clin Diagn Res       Date:  2015-11-01

2.  Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures.

Authors:  William W Tseng; Sam C Wang; Charles M Eichler; Robert S Warren; Eric K Nakakura
Journal:  World J Surg Oncol       Date:  2011-11-04       Impact factor: 2.754

3.  Surgical treatment of a retroperitoneal benign tumor surrounding important blood vessels by fractionated resection: A case report and review of the literature.

Authors:  Zhili Wan; Tiansheng Yin; Hongwei Chen; Dewei Li
Journal:  Oncol Lett       Date:  2016-03-31       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.